- 现金
- 62111 元
- 精华
- 26
- 帖子
- 30441
- 注册时间
- 2009-10-5
- 最后登录
- 2022-12-28
|
THE COURSE OF CHRONIC HBV INFECTION IN CHILDREN. WHEN SHOULD WE INITIATE ANTIVIRAL TREATMENT? A ROMANIAN 8 YEARS FOLLOW UP STUDY Speaker:
Oana Belei
Author:
O. Belei1*, I. Simedrea1, M. Pop2, L. Olariu1
Affiliation:
1First Pediatric Clinic, 2Third Pediatric Clinic, University of Medicine and Pharmacy Victor Babes, Timisoara, Romania. *[url=mailto[email protected]][email protected][/url]
Introduction:
Natural history studies show that the risk of development chronic HBV infection is inversely proportional with age of acquisition:25% of children infected at< 5 years develop chronic infection, versus< 10% adults.In Romania, treatment of HBV infection in children is limited to lamivudine (until 2009) and alpha2b standard interferon.Treatment of all children with chronic B hepatitis must be tempered by studying the natural history in children.Spontaneous HBeAg clearance is influenced by mode of transmission, viral load, necroinflammatory activity, immunocompetence, genotype.
Aim:
To investigate the rate of HBeAg/HBsAg seroconversion during childhood, spontaneous and after antiviral treatment.
Methods:
We retrospectively studied 176 children with chronic HBV infection and +HBeAg diagnosed between 2003-2011.The route of transmission was vertical in 92 and parenteral/unknown in 84 children.The mean age at diagnosis was7,5 years (6 months-16 years). In the lot with vertical transmission, 64 children emerged from HBe+Ag mothers with high viral load and 28 from HBe-/HBs+Ag mothers with low viral load.112 children were diagnosed in the first 4 years of life. HBV markers, viral load, clinical and liver function were tested at least once every 6 months.
Results:
24 (21%) of the 112 infected infants seroconvert in “e”system before 4 years without treatment. 3 (12%) infants with spontaneous HBeAg seroconversion emerged from HBe+Ag mothers compared to 6(25%) from HBe-Ag mothers and 15(63%) from noninfected mothers (p< 0,005).No spontaneous “s system” seroconversion was detected.58 children older than 4 years (HBs+Ag/HBe+Ag, hypertransaminasemia, detectable viral load, necroinflamatory activity) started antiviral treatment. HBe+Ag seroconversion and virusologic respond rate were 48% after 12 months of Interferon and 24%, respectively 45% after 12 months, respectively 24 months of Lamivudine(p< 0,005 at one year).HBsAg clearance was obtained in 2 cases (3%) after one year of Interferon and in 1 case (1.7%) after 2 years of Lamivudine.
Conclusions:
Maternal carrier status is very important: children of HBeAg seropositive mothers have lower rates of HBeAg seroconversion. Due to the possibility of spontaneous HBeAg seroconversion, antiviral treatment shouldn't be initiated in the first 4 years of life. HBsAg clearance rate was higher but not statistic significant in children who had anti-HBeAb achieved under Interferon treatment. |
|